47045-IND-T-CHRI-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">Joint Effort for Elimination of Tuberculosis (JEET) for patients seeking care in private sector - India (01-Jan-2018-31-Mar-2021)</narrative> India, Tuberculosis, Centre for Health Research and Innovation (CHRI)This program has the following goals: To achieve a rapid decining burden of TB morbidity and mortality while working towards elimination of TB in India by 2025. The objectives of this program are: Systematically engage the private provides with an increase in case notification to 2 million cases annually. Improving treatment adherence and treatment support byadoption of iCT tools and partnerships The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation Centre for Health Research and Innovation Centre for Health Research and Innovation The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division Gyongyver, JAKAB Fund Portfolio Manager +41 58 791 1700 gyongyver.jakab@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland India Multicomponent Tuberculosis Multicomponent -> Program management -> Grant management Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention) 1124073.08 4537374.11 4950476.06 4984668.75 -1854262.33 Global Fund Commitment to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 5155961.33 Global Fund Commitment to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) -1648376.24 Global Fund Commitment to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 7922851.07 Global Fund Commitment to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) -2565832.23 Global Fund Commitment to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 5106028.24 Global Fund Commitment to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) -772511.21 Global Fund Commitment to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 865897.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 723711.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 690473.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 1128225.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 1774989.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 248701.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 776056.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 579022.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 554438.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 1496628.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) -772511.21 Global Fund disbursement to IND-T-CHRIP01. Centre for Health Research and Innovation (CHRI) The Global Fund to Fight AIDS, Tuberculosis and Malaria 1064380.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 1348730.84 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) 865119.00 Global Fund disbursement to IND-T-CHRIP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Centre for Health Research and Innovation (CHRI) <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative xml:lang="en">Coverage / Output indicators targets and results for IND-T-CHRIP01</narrative> <narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> <narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> <narrative xml:lang="en">Outcome indicators targets and results for IND-T-CHRIP01</narrative> <narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> <narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative> <narrative xml:lang="en">Notification of RR-TB and/or MDR-TB cases – Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative> <narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative> <narrative xml:lang="en">Impact indicators targets and results for IND-T-CHRIP01</narrative> <narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>